1. Home
  2. SRTS vs DRIO Comparison

SRTS vs DRIO Comparison

Compare SRTS & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sensus Healthcare Inc.

SRTS

Sensus Healthcare Inc.

HOLD

Current Price

$3.06

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Logo DarioHealth Corp.

DRIO

DarioHealth Corp.

N/A

Current Price

$7.61

Market Cap

52.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SRTS
DRIO
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
44.3M
52.8M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
SRTS
DRIO
Price
$3.06
$7.61
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$7.00
$35.00
AVG Volume (30 Days)
24.5K
21.3K
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1559.02
EPS
N/A
1.25
Revenue
$27,482,000.00
$7,394,000.00
Revenue This Year
$2.00
$20.27
Revenue Next Year
$34.23
$47.58
P/E Ratio
N/A
$5.98
Revenue Growth
N/A
43.02
52 Week Low
$2.66
$0.38
52 Week High
$5.92
$17.74

Technical Indicators

Market Signals
Indicator
SRTS
DRIO
Relative Strength Index (RSI) 54.06 53.56
Support Level $2.87 $7.18
Resistance Level $3.17 $9.24
Average True Range (ATR) 0.13 0.61
MACD 0.01 0.10
Stochastic Oscillator 55.56 64.25

Price Performance

Historical Comparison
SRTS
DRIO

About SRTS Sensus Healthcare Inc.

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.

About DRIO DarioHealth Corp.

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.

Share on Social Networks: